Skip to main content
Health & Medicine

Selectively disrupting lysine acetyltransferase p300 and ZEB1 interaction prevents tumor progression while enhancing antitumor immunity.

| Source: Proceedings of the National Academy of Sciences of the United States of America

Both p300 acetyltransferase inhibitors and bromodomain inhibitors show therapeutic promise in cancer, but they mostly exhibit limited efficacy and may elicit severe adverse effects due to their lack of targeting selectivity. Thus, selectively disrupting p300 interactions with specific pro-oncogenic targets that are specifically expressed in neoplastic cells could serve as a safe and effective strategy for cancer treatment. Here, we demonstrate that p300 interacts with the pro-oncogenic transcrip

Both p300 acetyltransferase inhibitors and bromodomain inhibitors show therapeutic promise in cancer, but they mostly exhibit limited efficacy and may elicit severe adverse effects due to their lack of targeting selectivity. Thus, selectively disrupting p300 interactions with specific pro-oncogenic targets that are specifically expressed in neoplastic cells could serve as a safe and effective strategy for cancer treatment. Here, we demonstrate that p300 interacts with the pro-oncogenic transcription factor, ZEB1, and catalyzes its acetylation at an evolutionarily conserved K80 residue, stabilizing its expression in aggressive cancer cells. Ectopic expression of wild-type ZEB1 (mostly in acetylated status) but not the acetylation-deficient ZEB1 mutant modulates cytokinome of cancer cells, creating an immune-suppressive tumor microenvironment to support cancer progression. Underlining the importance of ZEB1 posttranslational processing, the K80-acetylated transcription factor is highly expressed in human cancers where its high-level expression is associated with poor prognosis. Importantly, we identify a small molecule compound, WY6, that undergoes high-affinity binding to p300 TAZ2 domain (a domain critical for ZEB1 binding) and consequently disrupts ZEB1 binding to p300, thereby suppressing K80 acetylation. WY6 treatment of tumor cells effectively represses p300-mediated ZEB1 acetylation, promoting its ubiquitination and subsequent degradation. Moreover, in vivo, WY6 potently suppresses orthotopic tumor growth without eliciting obvious toxic side effects and exhibits a synergetic effect when combined with PD-1/PD-L1 blockade immunotherapy. Collectively, our data demonstrate that selective disrupting of p300 and ZEB1 interaction effectively prevents tumor progression and may offer a promising therapeutic strategy for p300-ZEB1 axis-driven malignancies.

Read the original source →

Related Topics

Related Stories

Health & Medicine

Homeostatic control of stem cell activity during intestinal regeneration.

Stem cells proliferate rapidly to maintain tissue turnover during regeneration, yet the mechanisms preventing hyperproliferation remain unclear. Here, we identified nuclear factor Y (NF-Y) as a transcriptional repressor that maintains intestinal stem cell (ISC) quiescence. NF-Y restricts ISC proliferation by occupying the promoters of epidermal growth factor receptor (EGFR) signaling components, including Egfr , Mkp3 , Raf , Ras , and pnt , through regulation dependent on the histone acetyltrans

Continue reading
Health & Medicine

Spatial transcriptomics reveals organizational properties of the mouse spinal cord and alterations in neuropathic pain.

The spinal cord integrates diverse somatosensory inputs and executes motor outputs through anatomically and functionally distinct circuits. Here, we employed spatially resolved single-cell transcriptomic profiling of the adult mouse spinal cord to gain insights into the organizational logic of the spinal cord. Our results reveal distinct spatial and laminar distributions of neuronal subtypes, including axial level and sex-specific differences. Many neuronal subtypes exhibit lamina-specific somat

Continue reading
Health & Medicine

Acute degradation of Pumilio proteins reveals a biphasic posttranscriptional regulatory hierarchy in embryonic stem cell fate decision.

Posttranscriptional regulation is critical for mammalian embryogenesis yet has been underexplored. We previously showed that RNA-binding Pumilio proteins (Pum1/2) are essential for early mouse embryogenesis and embryonic stem cell (ESC) functions. Here, using acute protein degradation systems combined with time-resolved RNA sequencing and enhanced crosslinking and immunoprecipitation, we delineate a two-phase regulatory hierarchy modulated by Pum1/2 in mouse ESCs. The first phase, occurring with

Continue reading
Health & Medicine

Elastic interactions of mechanically polarizable cells.

Cells mechanically interact through the deformations they generate in their surrounding extracellular matrix. We present an analytical theory of the elastic interactions between cells that actively adapt their forces in response to local deformations of their environment. Cells are represented as localized contractile force generators, modeled as polarizable point force dipoles, whose adaptive forces are determined self-consistently with those of surrounding cells. Analysis of the associated ela

Continue reading
Health & Medicine

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection.

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potent

Continue reading